tetano
Editor, Senior Moderator
Stem Cell Res
. 2023 Jan 5;67:103018.
doi: 10.1016/j.scr.2023.103018. Online ahead of print.
Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
Martina Rabino[SUP] 1 [/SUP], Erica Rurali[SUP] 2 [/SUP], Chiara Zamboni[SUP] 2 [/SUP], Davide Rovina[SUP] 2 [/SUP], Sara Mallia[SUP] 2 [/SUP], Matteo Cauteruccio[SUP] 2 [/SUP], Andrea Baggiano[SUP] 3 [/SUP], Carlo Maria Giacari[SUP] 4 [/SUP], Milena Bellin[SUP] 5 [/SUP], Giulio Pompilio[SUP] 6 [/SUP]
Affiliations
Abstract
Coronavirus disease (COVID-19) is an infectious disease caused by SARS-CoV-2 virus, leading to mild to severe respiratory symptoms. Cardiovascular involvement is frequent and mainly manifests with myocarditis, arrhythmias, cardiac arrests, heart failure and coagulation abnormality. We generated human induced pluripotent stem cells (hiPSCs) from four COVID-19 patients, all characterized by increased levels of high-sensitivity Troponin I (hsTnI) during the infection acute phase, who developed (n = 2) or not (n = 2) severe myocarditis, as COVID-19 complication. The established hiPSCs were characterized for pluripotency and genomic stability, and constitute a useful resource for studying the mechanisms underlying the variability in COVID-19 severe cardiac manifestations.
. 2023 Jan 5;67:103018.
doi: 10.1016/j.scr.2023.103018. Online ahead of print.
Generation of four human induced pluripotent stem cell lines from COVID-19 hospitalized patients with increased levels of cardiac Troponin in the acute infection phase developing or not myocarditis
Martina Rabino[SUP] 1 [/SUP], Erica Rurali[SUP] 2 [/SUP], Chiara Zamboni[SUP] 2 [/SUP], Davide Rovina[SUP] 2 [/SUP], Sara Mallia[SUP] 2 [/SUP], Matteo Cauteruccio[SUP] 2 [/SUP], Andrea Baggiano[SUP] 3 [/SUP], Carlo Maria Giacari[SUP] 4 [/SUP], Milena Bellin[SUP] 5 [/SUP], Giulio Pompilio[SUP] 6 [/SUP]
Affiliations
- PMID: 36630840
- DOI: 10.1016/j.scr.2023.103018
Abstract
Coronavirus disease (COVID-19) is an infectious disease caused by SARS-CoV-2 virus, leading to mild to severe respiratory symptoms. Cardiovascular involvement is frequent and mainly manifests with myocarditis, arrhythmias, cardiac arrests, heart failure and coagulation abnormality. We generated human induced pluripotent stem cells (hiPSCs) from four COVID-19 patients, all characterized by increased levels of high-sensitivity Troponin I (hsTnI) during the infection acute phase, who developed (n = 2) or not (n = 2) severe myocarditis, as COVID-19 complication. The established hiPSCs were characterized for pluripotency and genomic stability, and constitute a useful resource for studying the mechanisms underlying the variability in COVID-19 severe cardiac manifestations.